Morinidazole
Modify Date: 2024-01-01 18:48:02
Morinidazole structure
|
Common Name | Morinidazole | ||
|---|---|---|---|---|
| CAS Number | 92478-27-8 | Molecular Weight | 270.285 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 521.4±50.0 °C at 760 mmHg | |
| Molecular Formula | C11H18N4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 269.2±30.1 °C | |
Use of MorinidazoleMorinidazole is a novel 5-nitroimidazole antimicrobial drug that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation, for the treatment of bacterial infections including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria. |
| Name | Morinidazole |
|---|---|
| Synonym | More Synonyms |
| Description | Morinidazole is a novel 5-nitroimidazole antimicrobial drug that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation, for the treatment of bacterial infections including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 521.4±50.0 °C at 760 mmHg |
| Molecular Formula | C11H18N4O4 |
| Molecular Weight | 270.285 |
| Flash Point | 269.2±30.1 °C |
| Exact Mass | 270.132813 |
| LogP | 0.46 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.632 |
| TUPWG40JAL |
| 1-(2-Methyl-5-nitro-1H-imidazol-1-yl)-3-(4-morpholinyl)-2-propanol |
| 4-Morpholineethanol, α-[(2-methyl-5-nitro-1H-imidazol-1-yl)methyl]- |